UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its holdings in Waystar Holding Corp. (NASDAQ:WAY – Free Report) by 13.3% during the 2nd quarter, Holdings Channel reports. The fund owned 169,608 shares of the company’s stock after selling 26,126 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Waystar were worth $3,482,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also recently added to or reduced their stakes in WAY. Royal Bank of Canada boosted its position in Waystar by 11.3% during the 1st quarter. Royal Bank of Canada now owns 21,609 shares of the company’s stock worth $808,000 after acquiring an additional 2,195 shares during the period. AQR Capital Management LLC acquired a new position in shares of Waystar during the first quarter valued at $203,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Waystar by 91.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,911 shares of the company’s stock valued at $1,753,000 after purchasing an additional 22,364 shares in the last quarter. NewEdge Advisors LLC bought a new stake in shares of Waystar during the first quarter valued at about $234,000. Finally, Goldman Sachs Group Inc. lifted its holdings in Waystar by 13.4% in the first quarter. Goldman Sachs Group Inc. now owns 747,268 shares of the company’s stock worth $27,918,000 after purchasing an additional 88,256 shares during the period.
Waystar Price Performance
NASDAQ:WAY opened at $23.06 on Friday. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.36. The business’s 50-day moving average price is $23.79 and its 200 day moving average price is $22.76. Waystar Holding Corp. has a 52-week low of $17.26 and a 52-week high of $40.35. The firm has a market cap of $4.42 billion, a P/E ratio of 32.94, a PEG ratio of 0.93 and a beta of 0.16.
Analyst Upgrades and Downgrades
WAY has been the subject of a number of recent analyst reports. Truist Financial decreased their target price on shares of Waystar from $38.00 to $33.00 and set a “buy” rating for the company in a research report on Thursday, August 13th. Needham & Company LLC reaffirmed a “buy” rating and issued a $33.00 price target on shares of Waystar in a research note on Wednesday, August 26th. Wall Street Zen cut shares of Waystar from a “buy” rating to a “hold” rating in a report on Sunday, May 24th. Wells Fargo & Company lowered their price objective on shares of Waystar from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Thursday, July 30th. Finally, Citigroup reissued a “buy” rating on shares of Waystar in a report on Monday, July 20th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Waystar currently has an average rating of “Moderate Buy” and an average price target of $35.14.
Get Our Latest Stock Analysis on Waystar
Insider Activity at Waystar
In related news, CEO Matthew Hawkins sold 82,500 shares of the business’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $25.97, for a total value of $2,142,525.00. Following the sale, the chief executive officer directly owned 1,804,794 shares in the company, valued at $46,870,500.18. The trade was a 4.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 165,000 shares of company stock valued at $4,206,524. 3.50% of the stock is owned by insiders.
Waystar Profile
Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
Read More
- Five stocks we like better than Waystar
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Want to see what other hedge funds are holding WAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waystar Holding Corp. (NASDAQ:WAY – Free Report).
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
